Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junyan Lu

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
Leukemia|May 22, 2021
The balance between the intronic miR-342 and its host gene Evl determines hematopoietic cell fate decisionFriederike Herbst, Tonio J L Lang, Elias S P Eckert, et al.
Blood|June 30, 2021
The protein landscape of chronic lymphocytic leukemiaFabienne Meier-Abt, Junyan Lu, Ester Cannizzaro, et al.
Molecular Cancer|March 2, 2025
BCL-2 dependence is a favorable predictive marker of response to therapy for chronic lymphocytic leukemiaStephen Jun Fei Chong, Junyan Lu, Rebecca Valentin, et al.
Molecular Systems Biology|August 12, 2022
Drug-microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLLPeter-Martin Bruch, Holly Ar Giles, Carolin Kolb, et al.
Nature|November 3, 2015
Structural insight into substrate preference for TET-mediated oxidationLulu Hu, Junyan Lu, Jingdong Cheng, et al.
Nature Communications|October 20, 2022
Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escapeMaurizio Mangolini, Alba Maiques-Diaz, Stella Charalampopoulou, et al.
Nature Cancer|October 2, 2023
Ex vivo drug response profiling for response and outcome prediction in hematologic malignancies: the prospective non-interventional SMARTrialNora Liebers, Peter-Martin Bruch, Tobias Terzer, et al.
Nature Chemistry|November 21, 2015
Inhibition of human copper trafficking by a small molecule significantly attenuates cancer cell proliferationJing Wang, Cheng Luo, Changliang Shan, et al.
Nature Cancer|August 23, 2021
Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemiaJunyan Lu, Ester Cannizzaro, Fabienne Meier-Abt, et al.
Nature Communications|July 9, 2020
IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasmsFerran Nadeu, Rut Mas-de-Les-Valls, Alba Navarro, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Leukemia|May 22, 2021
The balance between the intronic miR-342 and its host gene Evl determines hematopoietic cell fate decisionFriederike Herbst, Tonio J L Lang, Elias S P Eckert, et al.
Blood|June 30, 2021
The protein landscape of chronic lymphocytic leukemiaFabienne Meier-Abt, Junyan Lu, Ester Cannizzaro, et al.
Molecular Cancer|March 2, 2025
BCL-2 dependence is a favorable predictive marker of response to therapy for chronic lymphocytic leukemiaStephen Jun Fei Chong, Junyan Lu, Rebecca Valentin, et al.
Molecular Systems Biology|August 12, 2022
Drug-microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLLPeter-Martin Bruch, Holly Ar Giles, Carolin Kolb, et al.
Nature|November 3, 2015
Structural insight into substrate preference for TET-mediated oxidationLulu Hu, Junyan Lu, Jingdong Cheng, et al.
Nature Communications|October 20, 2022
Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escapeMaurizio Mangolini, Alba Maiques-Diaz, Stella Charalampopoulou, et al.
Nature Cancer|October 2, 2023
Ex vivo drug response profiling for response and outcome prediction in hematologic malignancies: the prospective non-interventional SMARTrialNora Liebers, Peter-Martin Bruch, Tobias Terzer, et al.
Nature Chemistry|November 21, 2015
Inhibition of human copper trafficking by a small molecule significantly attenuates cancer cell proliferationJing Wang, Cheng Luo, Changliang Shan, et al.
Nature Cancer|August 23, 2021
Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemiaJunyan Lu, Ester Cannizzaro, Fabienne Meier-Abt, et al.
Nature Communications|July 9, 2020
IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasmsFerran Nadeu, Rut Mas-de-Les-Valls, Alba Navarro, et al.
Pageof 10